Qube Research & Technologies LTD Trevena Inc Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.16 - $100.0 $3,041 - $1.9 Million	-19,007 Reduced 12.64%	131,348 $20,000
Q2 2022 Aug 15, 2022	BUY	$0.2 - $0.5 $30,071 - $75,177	150,355 New	150,355 $62,000
Q2 2021 Aug 13, 2021	SELL	$1.46 - $2.25 $35,734 - $55,071	-24,476 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.77 - $2.93 $668,451 - $1.11 Million	-377,656 Reduced 93.91%	24,476 $44,000
Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $514,371 - $787,254	241,489 Added 150.33%	402,132 $861,000
Q3 2020 Nov 12, 2020	BUY	$1.53 - $3.13 $66,799 - $136,655	43,660 Added 37.32%	160,643 $480,000
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.75 $56,151 - $204,720	116,983 New	116,983 $175,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.